The association of HIF1A gene polymorphism and its expression with ischemic stroke
- PMID: 40287478
- PMCID: PMC12033361
- DOI: 10.1038/s41598-025-99418-6
The association of HIF1A gene polymorphism and its expression with ischemic stroke
Abstract
Hypoxia-inducible factor 1 A (HIF1A) is considered as a potential marker gene for ischemic stroke (IS), its gene polymorphism may affect IS risk and may be related to the IS pathological process. In this study, a total of 159 IS patients and 141 healthy controls were enrolled by case-control study method. HIF1A three single nucleotide polymorphisms (SNPs: rs10873142, rs11549465, rs11549467) were genotyped by SNaPshot method and HIF1A protein levels was detected by enzyme-linked immunosorbent assay (ELISA), then the correlation between HIF-1 A SNPs and IS was analyzed by statistical analysis method. The genotype of HIF1A SNPs can affect the expression levels of clinical and laboratory parameters in IS patients, such as high-density lipoproteincholesterol (HDL-C), apolipoprotein A1, reactive oxygen species (ROS). HIF1A TCG haplotype is a protective factor for IS, HIF1A CCG haplotype is a risk factor for IS. However, the association between HIF1A rs10873142, rs11549465, rs11549467 genotypes and the IS risk was not statistically significant. ELISA analysis showed that the HIF1A expression of IS patients is higher than the healthy controls. Therefore, the gene polymorphism and expression of HIF1A may be related to IS pathological process, but the relationship between HIF1A gene polymorphism and the IS risk still needs further study.
Keywords: Gene polymorphism; HIF1A; Ischemic stroke; SNPs.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethics approval: All subjects signed informed consent before participating in the study. The study was conducted in accordance with the Declaration of Helsinki, the protocol was approved by the Ethics Committee of the Fourth People’s Hospital of Yunnan Province ((2020) YX No. (170)).
Figures









Similar articles
-
Role of HIF1A gene polymorphisms with serum uric acid and HIF-1α levels in monosodium urate crystal-induced arthritis.Clin Rheumatol. 2024 Nov;43(11):3477-3485. doi: 10.1007/s10067-024-07129-6. Epub 2024 Sep 11. Clin Rheumatol. 2024. PMID: 39256280
-
The association of genetic polymorphisms of hypoxia inducible factor-1 alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: A case-control study.Kaohsiung J Med Sci. 2017 Sep;33(9):433-441. doi: 10.1016/j.kjms.2017.05.014. Epub 2017 Jul 5. Kaohsiung J Med Sci. 2017. PMID: 28865600 Free PMC article.
-
HIF1A gene rs10873142 polymorphism is associated with risk of chronic obstructive pulmonary disease in a Chinese Han population: a case-control study.Biosci Rep. 2018 Mar 9;38(2):BSR20171309. doi: 10.1042/BSR20171309. Print 2018 Apr 27. Biosci Rep. 2018. PMID: 29339421 Free PMC article. Clinical Trial.
-
Association of Hypoxia-Inducible Factor 1α Gene Polymorphisms With Breast Cancer Susceptibility: A Meta-Analysis.JCO Glob Oncol. 2022 Mar;8:e2100399. doi: 10.1200/GO.21.00399. JCO Glob Oncol. 2022. PMID: 35507894 Free PMC article.
-
Association between HIF1A rs11549465 polymorphism and risk of prostate cancer: a meta-analysis.Oncotarget. 2017 Jul 4;8(27):44910-44916. doi: 10.18632/oncotarget.16489. Oncotarget. 2017. PMID: 28415653 Free PMC article. Review.
References
-
- Tuo, Q. Z., Zhang, S. T. & Lei, P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med. Res. Rev.42, 259–305. 10.1002/med.21817 (2022). - PubMed
-
- Au, A. Metabolomics and lipidomics of ischemic stroke. Adv. Clin. Chem.85, 31–69. 10.1016/bs.acc.2018.02.002 (2018). - PubMed
-
- Zhao, T. et al. Neural stem cells therapy for ischemic stroke: Progress and challenges. Transl Stroke Res.13 (5), 665–675. 10.1007/s12975-022-00984-y (2022). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical